Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices 74557 

Authority No. 523 of December 22, 

2021. 

Nicole L. Elkon, 

Deputy Assistant Secretary for Professional 

and Cultural Exchanges, Bureau of 

Educational and Cultural Affairs, Department 

of State. 

[FR Doc. 2023–23983 Filed 10–30–23; 8:45 am] 

BILLING CODE 4710–05–P 

DEPARTMENT OF TRANSPORTATION 

Federal Highway Administration 

[Docket No. FHWA–2023–0044] 

Agency Information Collection 

Activities: Notice of Request for 

Renewal of Currently Approved 

Information Collection 

AGENCY: Federal Highway 

Administration (FHWA), DOT. 

ACTION: Notice of request for renewal of 

currently approved information 

collection. 

SUMMARY: The FHWA invites public 

comments about our intention to request 

the Office of Management and Budget’s 

(OMB) approval for renewal of an 

existing information collection that is 

summarized below under 

SUPPLEMENTARY INFORMATION. We are 

required to publish this notice in the 

Federal Register by the Paperwork 

Reduction Act of 1995. 

DATES: Please submit comments by 

January 2, 2024. 

ADDRESSES: You may submit comments 

identified by DOT Docket Number 

FHWA–2023–0044 by any of the 

following methods: 

• Website: http://

www.regulations.gov. Follow the 

instructions for submitting comments 

on the DOT electronic docket site. 

• Fax: 1–202–493–2251. 

• Mail: Docket Management Facility; 

U.S. Department of Transportation, 1200 

New Jersey Avenue SE, Washington, DC 

20590. 

• Hand Delivery: U.S. Department of 

Transportation, 1200 New Jersey 

Avenue SE, Washington, DC 20590, 

between 9 a.m. and 5 p.m., Monday 

through Friday, except Federal holidays. 

Docket: For access to the docket to 

read background documents or 

comments received, go to http://

www.regulations.gov at any time or to 

U.S. Department of Transportation, 1200 

New Jersey Avenue SE, Washington, DC 

20590, between 9 a.m. and 5 p.m. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Omar Elkassed, (213) 894–6718, Office 

of Stewardship, Oversight, and Program 

Management, Federal Highway 

Administration, Department of 

Transportation, 888 South Figueroa 

Street, Suite 440, Los Angeles, CA 

90017. Office hours are from 7 a.m. to 

4 p.m., Monday through Friday, except 

Federal holidays. 

SUPPLEMENTARY INFORMATION: 

Title: Preparation and Execution of 

the Project Agreement and 

Modifications. 

OMB Control Number: 2125–0529. 

Background: Formal agreements 

between State Transportation 

Departments and the FHWA are 

required for Federal-aid highway 

projects. These agreements, referred to 

as ‘‘project agreements’’ are written 

contracts between the State and the 

Federal government that define the 

extent of work to be undertaken and 

commitments made concerning a 

highway project. Section 1305 of the 

Transportation Equity Act for the 21st 

Century (TEA–21, Pub. L. 105–178) 

amended 23 U.S.C. 106(a) and 

combined authorization of work and 

execution of the project agreement for a 

Federal-aid project into a single action. 

States continue to have the flexibility to 

use whatever format is suitable to 

provide the statutory information 

required, and burden estimates for this 

information collection are not changed. 

Respondents: There are 56 

respondents, including 50 State 

Transportation Departments, the District 

of Columbia, the Commonwealth of 

Puerto Rico, the Commonwealth of the 

Northern Mariana Islands, Guam, the 

Virgin Islands and American Samoa. 

Depending on the size of and activity in 

the above government agencies, the 

number of project agreements executed 

in any agency ranges between 10 and 

1,500. 

Frequency: On an on-going basis as 

project agreements are written. 

Estimated Average Annual Burden 

per Response: There is a total of 23,809 

agreements per year. Each agreement 

requires 1 hour to complete. 

Estimated Total Annual Burden 

Hours: 23,809 hours. 

Public Comments Invited: You are 

asked to comment on any aspect of this 

information collection, including: (1) 

whether the proposed collection is 

necessary for the FHWA’s performance; 

(2) the accuracy of the estimated 

burdens; (3) ways for the FHWA to 

enhance the quality, usefulness, and 

clarity of the collected information; and 

(4) ways that the burden could be 

minimized, including the use of 

electronic technology, without reducing 

the quality of the collected information. 

The agency will summarize and/or 

include your comments in the request 

for OMB’s clearance of this information 

collection. 

Authority: The Paperwork Reduction 

Act of 1995; 44 U.S.C. chapter 35, as 

amended; and 49 CFR 1.48. 

Issued on: October 26, 2023. 

Jazmyne Lewis, 

Information Collection Officer. 

[FR Doc. 2023–23997 Filed 10–30–23; 8:45 am] 

BILLING CODE 4910–22–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2023–0038] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 

ACTION: Notice of applications for 

exemption; request for comments. 

SUMMARY: FMCSA announces receipt of 

applications from 17 individuals for an 

exemption from the prohibition in the 

Federal Motor Carrier Safety 

Regulations (FMCSRs) against persons 

with a clinical diagnosis of epilepsy or 

any other condition that is likely to 

cause a loss of consciousness or any loss 

of ability to control a commercial motor 

vehicle (CMV) to drive in interstate 

commerce. If granted, the exemptions 

would enable these individuals who 

have had one or more seizures and are 

taking anti-seizure medication to 

operate CMVs in interstate commerce. 

DATES: Comments must be received on 

or before November 30, 2023. 

ADDRESSES: You may submit comments 

identified by the Federal Docket 

Management System Docket No. 

FMCSA–2023–0038 using any of the 

following methods: 

• Federal eRulemaking Portal: Go to 

www.regulations.gov/, insert the docket 

number (FMCSA–2023–0038) in the 

keyword box and click ‘‘Search.’’ Next, 

choose the only notice listed, and click 

on the ‘‘Comment’’ button. Follow the 

online instructions for submitting 

comments. 

• Mail: Dockets Operations; U.S. 

Department of Transportation, 1200 

New Jersey Avenue SE, West Building 

Ground Floor, Washington, DC 20590– 

0001. 

• Hand Delivery: West Building 

Ground Floor, 1200 New Jersey Avenue 

SE, Washington, DC, 20590–0001 

between 9 a.m. and 5 p.m. ET Monday 

through Friday, except Federal 

Holidays. 


lotter on DSK11XQN23PROD with NOTICES1
74558 Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices 

1These criteria may be found in APPENDIX A TO 

PART 391—MEDICAL ADVISORY CRITERIA, 

section H. Epilepsy: § 391.41(b)(8), paragraphs 3, 4, 

and 5, which is available on the internet at https:// 

www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/ 

CFR-2015-title49-vol5-part391-appA.pdf. 

• Fax: (202) 493–2251. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

instructions on submitting comments. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, FMCSA, DOT, 1200 

New Jersey Avenue SE, Washington, DC 

20590–0001, (202) 366–4001, 

fmcsamedical@dot.gov. Office hours are 

8:30 a.m. to 5 p.m. ET Monday through 

Friday, except Federal holidays. If you 

have questions regarding viewing or 

submitting material to the docket, 

contact Dockets Operations, (202) 366– 

9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (Docket No. FMCSA–2023–0038), 

indicate the specific section of this 

document to which each comment 

applies, and provide a reason for each 

suggestion or recommendation. You 

may submit your comments and 

material online or by fax, mail, or hand 

delivery, but please use only one of 

these means. FMCSA recommends that 

you include your name and a mailing 

address, an email address, or a phone 

number in the body of your document 

so that FMCSA can contact you if there 

are questions regarding your 

submission. 

To submit your comment online, go to 

https://www.regulations.gov/docket/ 

FMCSA-2023-0038. Next, choose the 

only notice listed, click the ‘‘Comment’’ 

button, and type your comment into the 

text box on the following screen. Choose 

whether you are submitting your 

comment as an individual or on behalf 

of a third party and then submit. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. FMCSA will consider 

all comments and material received 

during the comment period. 

B. Viewing Comments 

To view comments go to 

www.regulations.gov. Insert the docket 

number (FMCSA–2023–0038) in the 

keyword box and click ‘‘Search.’’ Next, 

choose the only notice listed, and click 

‘‘Browse Comments.’’ If you do not have 

access to the internet, you may view the 

docket online by visiting Dockets 

Operations on the ground floor of the 

DOT West Building, 1200 New Jersey 

Avenue SE, Washington, DC 20590– 

0001, between 9 a.m. and 5 p.m. ET 

Monday through Friday, except Federal 

holidays. To be sure someone is there to 

help you, please call (202) 366–9317 or 

(202) 366–9826 before visiting Dockets 

Operations. 

C. Privacy Act 

In accordance with 49 U.S.C. 

31315(b)(6), DOT solicits comments 

from the public on the exemption 

request. DOT posts these comments, 

without edit, including any personal 

information the commenter provides, to 

www.regulations.gov. As described in 

the system of records notice DOT/ALL 

14 (Federal Docket Management 

System), which can be reviewed at 

https://www.transportation.gov/ 

individuals/privacy/privacy-act-systemrecords-notices, the comments are 

searchable by the name of the submitter. 

II. Background 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the FMCSRs for no 

longer than a 5-year period if it finds 

such exemption would likely achieve a 

level of safety that is equivalent to, or 

greater than, the level that would be 

achieved absent such exemption. The 

statutes also allow the Agency to renew 

exemptions at the end of the 5-year 

period. FMCSA grants medical 

exemptions from the FMCSRs for a 2- 

year period to align with the maximum 

duration of a driver’s medical 

certification. 

The 17 individuals listed in this 

notice have requested an exemption 

from the epilepsy and seizure disorders 

prohibition in 49 CFR 391.41(b)(8). 

Accordingly, the Agency will evaluate 

the qualifications of each applicant to 

determine whether granting the 

exemption will achieve the required 

level of safety mandated by statute. 

The physical qualification standard 

for drivers regarding epilepsy found in 

§ 391.41(b)(8) states that a person is 

physically qualified to drive a CMV if 

that person has no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause the loss of consciousness or any 

loss of ability to control a CMV. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist medical examiners (MEs) in 

determining whether drivers with 

certain medical conditions are qualified 

to operate a CMV in interstate 

commerce. 

The criteria states that if an individual 

has had a sudden episode of a nonepileptic seizure or loss of 

consciousness of unknown cause that 

did not require anti-seizure medication, 

the decision whether that person’s 

condition is likely to cause the loss of 

consciousness or loss of ability to 

control a CMV should be made on an 

individual basis by the ME in 

consultation with the treating physician. 

Before certification is considered, it is 

suggested that a 6-month waiting period 

elapse from the time of the episode. 

Following the waiting period, it is 

suggested that the individual have a 

complete neurological examination. If 

the results of the examination are 

negative and anti-seizure medication is 

not required, then the driver may be 

qualified. 

In those individual cases where a 

driver has had a seizure or an episode 

of loss of consciousness that resulted 

from a known medical condition (e.g., 

drug reaction, high temperature, acute 

infectious disease, dehydration, or acute 

metabolic disturbance), certification 

should be deferred until the driver has 

recovered fully from that condition, has 

no existing residual complications, and 

is not taking anti-seizure medication. 

Drivers who have a history of 

epilepsy/seizures, off anti-seizure 

medication, and seizure-free for 10 

years, may be qualified to operate a 

CMV in interstate commerce. Interstate 

drivers with a history of a single 

unprovoked seizure may be qualified to 

drive a CMV in interstate commerce if 

seizure-free and off anti-seizure 

medication for a 5-year period or more. 

As a result of MEs misinterpreting 

advisory criteria as regulation, 

numerous drivers have been prohibited 

from operating a CMV in interstate 

commerce based on the fact that they 

have had one or more seizures and are 

taking anti-seizure medication, rather 

than an individual analysis of their 

circumstances by a qualified ME based 

on the physical qualification standards 

and medical best practices. 

On January 15, 2013, FMCSA 

announced in a notice of final 

disposition titled, ‘‘Qualification of 

Drivers; Exemption Applications; 

Epilepsy and Seizure Disorders,’’ (78 FR 

3069), its decision to grant requests from 

22 individuals for exemptions from the 

regulatory requirement that interstate 

CMV drivers have ‘‘no established 

medical history or clinical diagnosis of 

epilepsy or any other condition which 

is likely to cause loss of consciousness 

or any loss of ability to control a CMV.’’ 

Since that time, the Agency has 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices 74559 

published additional notices granting 

requests from individuals for 

exemptions from the regulatory 

requirement regarding epilepsy found in 

§ 391.41(b)(8). 

To be considered for an exemption 

from the epilepsy and seizure disorders 

prohibition in § 391.41(b)(8), applicants 

must meet the criteria in the 2007 

recommendations of the Agency’s 

Medical Expert Panel (78 FR 3069). 

III. Qualifications of Applicants 

James Byrd 

James Byrd is a 56-year-old class D 

license holder in Tennessee. They have 

a history of seizure disorder and have 

been seizure free since 2013. They take 

anti-seizure medication with the dosage 

and frequency remaining the same since 

2021. Their physician states that they 

are supportive of James Byrd receiving 

an exemption. 

Francis Chiacchieri 

Francis Chiacchieri is a 66-year-old 

class B commercial driver’s license 

(CDL) holder in Massachusetts. They 

have a history of oligodendroglioma and 

have been seizure free since September 

2001. They take anti-seizure medication 

with the dosage and frequency 

remaining the same since February 

2002. Their physician states that they 

are supportive of Francis Chiacchieri 

receiving an exemption. 

Lane Freeman 

Lane Freeman is a 26-year-old class E 

license holder in Florida. They have a 

history of generalized epilepsy and have 

been seizure free since April 1, 2013. 

They take anti-seizure medication with 

the dosage and frequency remaining the 

same since November 3, 2011. Their 

physician states that they are supportive 

of Lane Freeman receiving an 

exemption. 

Jeffrey Gomall 

Jeffrey Gomall is a 52-year-old class D 

license holder in Minnesota. They have 

a history of generalized epilepsy and 

have been seizure free since 2002. They 

take anti-seizure medication with the 

dosage and frequency remaining the 

same since 2008. Their physician states 

that they are supportive of Jeffrey 

Gomall receiving an exemption. 

Christine Green-McClure 

Christine Green-McClure is a 50-yearold class D license holder in New York. 

They have a history of seizure disorder 

and have been seizure free since 2007. 

They take anti-seizure medication with 

the dosage and frequency remaining the 

same since 2007. Their physician states 

that they are supportive of Christine 

Green-McClure receiving an exemption. 

Nicholas Hayes 

Nicholas Hayes is a 32-year-old class 

B CDL holder in Virginia. They have a 

history of an isolated seizure and have 

been seizure free since July 26, 2012. 

They take anti-seizure medication with 

the dosage and frequency remaining the 

same since August 2012. Their 

physician states that they are supportive 

of Nicholas Hayes receiving an 

exemption. 

Alex Hohman 

Alex Hohman is a 22-year-old class C 

license holder in Pennsylvania. They 

have a history of epilepsy and have been 

seizure free since August 2015. They 

take anti-seizure medication with the 

dosage and frequency remaining the 

same since August 2015. Their 

physician states that they are supportive 

of Alex Hohman receiving an 

exemption. 

Michelle Hughes 

Michelle Hughes is a 45-year-old class 

C license holder in North Carolina. They 

have a history of epilepsy and have been 

seizure free since 2007. They take antiseizure medication with the dosage and 

frequency remaining the same since 

2017. Their physician states that they 

are supportive of Michelle Hughes 

receiving an exemption. 

Michael Keys 

Michael Keys is a 44-year-old class C 

license holder in Pennsylvania. They 

have a history of seizure disorder and 

have been seizure free since July 13, 

2010. They take anti-seizure medication 

with the dosage and frequency 

remaining the same since September 

2010. Their physician states that they 

are supportive of Michael Keys 

receiving an exemption. 

Matthew Lee 

Matthew Lee is a 48-year-old class CM 

license holder in Georgia. They have a 

history of epilepsy and have been 

seizure free since February 2003. They 

take anti-seizure medication with the 

dosage and frequency remaining the 

same since 2003. Their physician states 

that they are supportive of Matthew Lee 

receiving an exemption. 

Lisa Martin 

Lisa Martin is a 41-year-old class D 

license holder in New York. They have 

a history of epilepsy and have been 

seizure free since 1994. They take antiseizure medication with the dosage and 

frequency remaining the same since 

2012. Their physician states that they 

are supportive of Lisa Martin receiving 

an exemption. 

Pedro Martinez 

Pedro Martinez is a 36-year-old class 

C license holder in Texas. They have a 

history of epilepsy and have been 

seizure free since 2012. They take antiseizure medication with the dosage and 

frequency remaining the same since 

October 2002. Their physician states 

that they are supportive of Pedro 

Martinez receiving an exemption. 

Cecil Massey 

Cecil Massey is a 33-year-old class R 

license holder in Mississippi. They have 

a history of epilepsy and have been 

seizure free since May 2015. They take 

anti-seizure medication with the dosage 

and frequency remaining the same since 

December 2009. Their physician states 

that they are supportive of Cecil Massey 

receiving an exemption. 

James Philips 

James Phillips is a 29-year-old class B 

CDL holder in North Carolina. They 

have a history of focal epilepsy and 

have been seizure free since 2012. They 

take anti-seizure medication with the 

dosage and frequency remaining the 

same since 2012. Their physician states 

that they are supportive of James 

Phillips receiving an exemption. 

Joshua Pike 

Joshua Pike is a 33-year-old class C 

license holder in Maine. They have a 

history of nocturnal generalized 

convulsions and have been seizure free 

since May 2014. They take anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2016. Their physician states that they 

are supportive of Joshua Pike receiving 

an exemption. 

Alex Ramerth 

Alex Ramerth is a 41-year-old class D 

license holder in Minnesota. They have 

a history of generalized epilepsy and 

have been seizure free since 2010. They 

take anti-seizure medication with the 

dosage and frequency remaining the 

same since 2010. Their physician states 

that they are supportive of Alex 

Ramerth receiving an exemption. 

Maciej Skrzyniarz 

Maciej Skrzyniarz is a 36-year-old 

class A license holder in Illinois. They 

have a history of generalized epilepsy 

and have been seizure free since 2014. 

They take anti-seizure medication with 

the dosage and frequency remaining the 

same since 2014. Their physician states 

that they are supportive of Maciej 

Skrzyniarz receiving an exemption. 


lotter on DSK11XQN23PROD with NOTICES1
74560 Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices 

IV. Request for Comments 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), FMCSA requests public 

comment from all interested persons on 

the exemption petitions described in 

this notice. We will consider all 

comments received before the close of 

business on the closing date indicated 

under the DATES section of the notice. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2023–23966 Filed 10–30–23; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2014–0383; FMCSA– 

2014–0385; FMCSA–2014–0387; FMCSA– 

2018–0139; FMCSA–2019–0109; FMCSA– 

2019–0110; FMCSA–2021–0015] 

Qualification of Drivers; Exemption 

Applications; Hearing 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 

ACTION: Notice of renewal of 

exemptions; request for comments. 

SUMMARY: FMCSA announces its 

decision to renew exemptions for 13 

individuals from the hearing 

requirement in the Federal Motor 

Carrier Safety Regulations (FMCSRs) for 

interstate commercial motor vehicle 

(CMV) drivers. The exemptions enable 

these hard of hearing and deaf 

individuals to continue to operate CMVs 

in interstate commerce. 

DATES: The exemptions are applicable 

on November 19, 2023. The exemptions 

expire on November 19, 2025. 

Comments must be received on or 

before November 30, 2023. 

ADDRESSES: You may submit comments 

identified by the Federal Docket 

Management System Docket No. 

FMCSA–2014–0383, Docket No. 

FMCSA–2014–0385, Docket No. 

FMCSA–2014–0387, Docket No. 

FMCSA–2018–013, Docket No. FMCSA– 

2019–0109, Docket No. FMCSA–2019– 

0110, or Docket No. FMCSA–2021–0015 

using any of the following methods: 

• Federal eRulemaking Portal: Go to 

www.regulations.gov, insert the docket 

number (FMCSA–2014–0383, FMCSA– 

2014–0385, FMCSA–2014–0387, 

FMCSA–2018–0139, FMCSA–2019– 

0109, FMCSA–2019–0110, or FMCSA– 

2021–0015) in the keyword box and 

click ‘‘Search.’’ Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, and click on the 

‘‘Comment’’ button. Follow the online 

instructions for submitting comments. 

• Mail: Dockets Operations; U.S. 

Department of Transportation, 1200 

New Jersey Avenue SE, West Building 

Ground Floor, Washington, DC 20590– 

0001. 

• Hand Delivery: West Building 

Ground Floor, 1200 New Jersey Avenue 

SE, Washington, DC 20590–0001, 

between 9 a.m. and 5 p.m. ET Monday 

through Friday, except Federal 

Holidays. 

• Fax: (202) 493–2251. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

instructions on submitting comments. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, FMCSA, DOT, 1200 

New Jersey Avenue SE, Room W64–224, 

Washington, DC 20590–0001, (202) 366– 

4001, fmcsamedical@dot.gov. Office 

hours are 8:30 a.m. to 5 p.m. ET Monday 

through Friday, except Federal holidays. 

If you have questions regarding viewing 

or submitting material to the docket, 

contact Dockets Operations, (202) 366– 

9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (Docket No. FMCSA–2014–0383, 

Docket No. FMCSA–2014–0385, Docket 

No. FMCSA–2014–0387, Docket No. 

FMCSA–2018–0139, Docket No. 

FMCSA–2019–0109, Docket No. 

FMCSA–2019–0110, or Docket No. 

FMCSA–2021–0015), indicate the 

specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. You may submit your 

comments and material online or by fax, 

mail, or hand delivery, but please use 

only one of these means. FMCSA 

recommends that you include your 

name and a mailing address, an email 

address, or a phone number in the body 

of your document so that FMCSA can 

contact you if there are questions 

regarding your submission. 

To submit your comment online, go to 

www.regulations.gov/, insert the docket 

number (FMCSA–2014–0383, FMCSA– 

2014–0385, FMCSA–2014–0387, 

FMCSA–2018–0139, FMCSA–2019– 

0109, FMCSA–2019–0110, or FMCSA– 

2021–0015) in the keyword box and 

click ‘‘Search.’’ Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, click the ‘‘Comment’’ 

button, and type your comment into the 

text box on the following screen. Choose 

whether you are submitting your 

comment as an individual or on behalf 

of a third party and then submit. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. FMCSA will consider 

all comments and material received 

during the comment period. 

B. Viewing Comments 

To view comments go to 

www.regulations.gov. Insert the docket 

number (FMCSA–2014–0383, FMCSA– 

2014–0385, FMCSA–2014–0387, 

FMCSA–2018–0139, FMCSA–2019– 

0109, FMCSA–2019–0110, or FMCSA– 

2021–0015) in the keyword box and 

click ‘‘Search.’’ Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, and click ‘‘Browse 

Comments.’’ If you do not have access 

to the internet, you may view the docket 

online by visiting Dockets Operations 

on the ground floor of the DOT West 

Building, 1200 New Jersey Avenue SE, 

Washington, DC 20590–0001, between 9 

a.m. and 5 p.m. ET Monday through 

Friday, except Federal holidays. To be 

sure someone is there to help you, 

please call (202) 366–9317 or (202) 366– 

9826 before visiting Dockets Operations. 

C. Privacy Act 

In accordance with 49 U.S.C. 

31315(b)(6), DOT solicits comments 

from the public on the exemption 

requests. DOT posts these comments, 

without edit, including any personal 

information the commenter provides, to 

www.regulations.gov. As described in 

the system of records notice DOT/ALL 

14 (Federal Docket Management 

System), which can be reviewed at 

https://www.transportation.gov/ 

individuals/privacy/privacy-act-systemrecords-notices, the comments are 

searchable by the name of the submitter. 

II. Background 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the FMCSRs for no 

longer than a 5-year period if it finds 

such exemption would likely achieve a 

level of safety that is equivalent to, or 

greater than, the level that would be 

achieved absent such exemption. The 

statutes also allow the Agency to renew 

exemptions at the end of the 5-year 

period. FMCSA grants medical 

exemptions from the FMCSRs for a 2- 

year period to align with the maximum 

duration of a driver’s medical 

certification. 

The physical qualification standard 

for drivers regarding hearing found in 


lotter on DSK11XQN23PROD with NOTICES1